Molecular Partners AG
IPOPIONEERING DARPin THERAPEUTICS - Molecular Partners
Public · Zurich, Switzerland · Founded 2004 · $15.6M raised
- Headquarters
- Zurich
- Employees
- 51–200
- Founded
- 2004
- Business Model
- B2B
- Website
- molecularpartners.com
- Total Funding
- $15.6M
- Last Round
- $15.6M Series BDec 2009
- Rounds
- 2
- Type
- Public
About
Clinical-stage biotech pioneering DARPin therapeutics for cancer and serious diseases, with a diverse oncology pipeline.
Summary
Molecular Partners AG is a Biotech company based in Zurich, Switzerland, founded in 2004. It has raised $15.6M in total across 2 rounds, most recently a $15.6M Series B round in Dec 2009.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2024
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...